|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.903
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.553
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.474
|
Human |
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.460
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.399
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.364
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.347
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.329
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.310
|
Human |
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.306
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.291
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.288
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.209
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.203
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.199
|
|
|
|
positive regulation of triglyceride metabolic process
|
GO:0090208 |
9 |
0.173
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.169
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.168
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.163
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.161
|
Human |
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.160
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.159
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.156
|
|
|
|
positive regulation of lipid storage
|
GO:0010884 |
10 |
0.155
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.153
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.151
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.149
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.148
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.139
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.138
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.133
|
Worm |
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.130
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.129
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.128
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.124
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.117
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.114
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.111
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.111
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.109
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.106
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.105
|
Human |
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.102
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.101
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.100
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.099
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.098
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.097
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.096
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.095
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.094
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.094
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.093
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.093
|
Human |
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.092
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.092
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.092
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.091
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.090
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.090
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.089
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.088
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.086
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.085
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.084
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.083
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.083
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.082
|
|
|
|
lamellipodium morphogenesis
|
GO:0072673 |
5 |
0.082
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.081
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.081
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.081
|
|
|
|
negative regulation of fatty acid oxidation
|
GO:0046322 |
5 |
0.079
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.078
|
Worm |
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.078
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.076
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.074
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.073
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.073
|
Human |
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.072
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.072
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.072
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.071
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.071
|
Human |
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.070
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.069
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.069
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.067
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.067
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.066
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.066
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.066
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.066
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.066
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.066
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.066
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.065
|
|
|
|
acylglycerol biosynthetic process
|
GO:0046463 |
18 |
0.065
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.065
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.065
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.064
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.063
|
|
|
|
adherens junction organization
|
GO:0034332 |
28 |
0.063
|
|
|
|
positive regulation of phagocytosis engulfment
|
GO:0060100 |
3 |
0.063
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.063
|
Human |
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.062
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.062
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.062
|
Worm |
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
21 |
0.062
|
|
|
|
acylglycerol catabolic process
|
GO:0046464 |
11 |
0.062
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.061
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.061
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.060
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.060
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.059
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.058
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.058
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.058
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.058
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.057
|
|
|
|
positive regulation of sequestering of triglyceride
|
GO:0010890 |
4 |
0.057
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.057
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.057
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.057
|
Worm |
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.056
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.056
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.056
|
Human |
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.055
|
|
|
|
adherens junction assembly
|
GO:0034333 |
22 |
0.055
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.054
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.054
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.053
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.053
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.053
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.053
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.052
|
|
|
|
focal adhesion assembly
|
GO:0048041 |
19 |
0.052
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.052
|
|
|
|
positive regulation of lipid biosynthetic process
|
GO:0046889 |
18 |
0.052
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.052
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.051
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.051
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.051
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.051
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.051
|
Worm |
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.050
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.050
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.050
|
|
|
|
triglyceride biosynthetic process
|
GO:0019432 |
17 |
0.050
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.048
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.048
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.047
|
|
|
|
positive regulation of engulfment of apoptotic cell
|
GO:1901076 |
1 |
0.047
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.047
|
Human |
|
|
cell substrate adherens junction assembly
|
GO:0007045 |
19 |
0.046
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.046
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.046
|
|
|
|
microtubule cytoskeleton organization involved in mitosis
|
GO:1902850 |
4 |
0.045
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.045
|
|
|
|
membrane tubulation
|
GO:0097320 |
4 |
0.045
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.045
|
|
|
|
synaptic vesicle transport
|
GO:0048489 |
57 |
0.045
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.045
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.044
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
34 |
0.044
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.044
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.044
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.043
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.043
|
|
|
|
negative regulation of reactive oxygen species metabolic process
|
GO:2000378 |
10 |
0.043
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.042
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.042
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.042
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.042
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.041
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.041
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.041
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.040
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.040
|
|
|
|
cell substrate junction assembly
|
GO:0007044 |
24 |
0.040
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.040
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.039
|
Human |
|
|
muscle cell development
|
GO:0055001 |
133 |
0.039
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.039
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.039
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.039
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.038
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.037
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.037
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.037
|
|
|
|
regulation of lipid storage
|
GO:0010883 |
20 |
0.036
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.036
|
Worm |
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.036
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.035
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.035
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.035
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.035
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.035
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.035
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.034
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.034
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.034
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.034
|
|
|
|
triglyceride catabolic process
|
GO:0019433 |
9 |
0.034
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.034
|
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
0.034
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.033
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.033
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.033
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.032
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.032
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.032
|
|
|
|
positive regulation of fatty acid beta oxidation
|
GO:0032000 |
1 |
0.032
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.031
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.031
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.031
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.031
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.031
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.031
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.030
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.030
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.030
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.030
|
|
|
|
regulation of protein tyrosine kinase activity
|
GO:0061097 |
17 |
0.030
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.030
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.030
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.030
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.030
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.030
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.029
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.029
|
Human |
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.029
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.029
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.029
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.029
|
Worm |
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.028
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.028
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.028
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.028
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.028
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.028
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.027
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.027
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.027
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.027
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.027
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.027
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.027
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.027
|
|
|
|
positive regulation of apoptotic cell clearance
|
GO:2000427 |
3 |
0.026
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.026
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.026
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.026
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.026
|
|
|
|
neutral lipid biosynthetic process
|
GO:0046460 |
18 |
0.026
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.026
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.026
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.025
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.025
|
|
|
|
establishment of synaptic vesicle localization
|
GO:0097480 |
57 |
0.025
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.025
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.025
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.025
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.025
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.025
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.025
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.025
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.025
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.025
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.024
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.024
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.024
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.024
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.024
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.024
|
|
|
|
axon cargo transport
|
GO:0008088 |
33 |
0.024
|
|
|
|
filopodium assembly
|
GO:0046847 |
19 |
0.024
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.024
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.024
|
|
|
|
regulation of fatty acid beta oxidation
|
GO:0031998 |
1 |
0.024
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.024
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.024
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.024
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.024
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.023
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.023
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.023
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.023
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.023
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.023
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.023
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.023
|
|
|
|
early endosome to late endosome transport
|
GO:0045022 |
2 |
0.023
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.023
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.023
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.023
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.023
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.023
|
Worm |
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.023
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.023
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.023
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.023
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.022
|
|
|
|
negative regulation of peroxisome proliferator activated receptor signaling pathway
|
GO:0035359 |
3 |
0.022
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.022
|
|
|
|
mitochondrion localization
|
GO:0051646 |
9 |
0.022
|
|
|
|
neutral lipid catabolic process
|
GO:0046461 |
11 |
0.022
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.022
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.022
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.022
|
|
|
|
microtubule based transport
|
GO:0010970 |
50 |
0.022
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.022
|
|
|
|
reproductive behavior
|
GO:0019098 |
32 |
0.022
|
Worm |
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.022
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.022
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.022
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.022
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.022
|
Worm |
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.022
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.022
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.021
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.021
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.021
|
|
|
|
learning
|
GO:0007612 |
98 |
0.021
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.021
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.021
|
|
|
|
glycerolipid catabolic process
|
GO:0046503 |
16 |
0.021
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.021
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.021
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.021
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.021
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.021
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.020
|
|
|
|
negative regulation of fatty acid metabolic process
|
GO:0045922 |
10 |
0.020
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.020
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.020
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.020
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.020
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.020
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.020
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.020
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.020
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.020
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.020
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.020
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.020
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.020
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.020
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.020
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.020
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.020
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.019
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.019
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.019
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.019
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.019
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.019
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.019
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.019
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.019
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.019
|
Worm |
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.019
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.019
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.019
|
Worm |
|
|
positive regulation of actin filament polymerization
|
GO:0030838 |
26 |
0.019
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.019
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.019
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.019
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.018
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.018
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.018
|
|
|
|
cytokinetic process
|
GO:0032506 |
2 |
0.018
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.018
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.018
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.018
|
|
|
|
cell adhesion mediated by integrin
|
GO:0033627 |
18 |
0.018
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.018
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.018
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.018
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.018
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.018
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.018
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.018
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.018
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.018
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.018
|
|
|
|
regulation of lipid catabolic process
|
GO:0050994 |
15 |
0.017
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.017
|
|
|
|
lipid particle organization
|
GO:0034389 |
7 |
0.017
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.017
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.017
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.017
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.017
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.017
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.017
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.017
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.017
|
|
|
|
positive regulation of lamellipodium organization
|
GO:1902745 |
3 |
0.017
|
Human |
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.017
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.017
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.017
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.017
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.017
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.017
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.017
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.017
|
|
|
|
regulation of actin filament bundle assembly
|
GO:0032231 |
18 |
0.016
|
Human |
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.016
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.016
|
|
|
|
positive regulation of necrotic cell death
|
GO:0010940 |
1 |
0.016
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.016
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.016
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.016
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.016
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.016
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.016
|
|
|
|
translation
|
GO:0006412 |
93 |
0.016
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.016
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.016
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.016
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.016
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.016
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.016
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.016
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.016
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.016
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.015
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.015
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.015
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.015
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.015
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.015
|
Human |
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.015
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.015
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.015
|
|
|
|
megakaryocyte development
|
GO:0035855 |
15 |
0.015
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.015
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.015
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.015
|
|
|
|
positive regulation of triglyceride biosynthetic process
|
GO:0010867 |
6 |
0.015
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.015
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.015
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.015
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.015
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.015
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.015
|
|
|
|
negative regulation of lipase activity
|
GO:0060192 |
7 |
0.015
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.015
|
|
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.015
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.015
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.015
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.015
|
|
|
|
positive regulation of lamellipodium assembly
|
GO:0010592 |
2 |
0.015
|
Human |
|
|
regulation of establishment of protein localization to plasma membrane
|
GO:0090003 |
12 |
0.015
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.015
|
|
|
|
regulation of triglyceride catabolic process
|
GO:0010896 |
5 |
0.015
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.015
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.014
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.014
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.014
|
|
|
|
spindle assembly involved in mitosis
|
GO:0090307 |
4 |
0.014
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.014
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.014
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.014
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.014
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.014
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.014
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.014
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.014
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.014
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.014
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.014
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.014
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.014
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.014
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.014
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.014
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.014
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.014
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.014
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.014
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.014
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.014
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.014
|
|
|
|
regulation of neurotransmitter transport
|
GO:0051588 |
35 |
0.014
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.014
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.014
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.014
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.014
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.013
|
|
